1.FK506-binding proteins and neurodegenerative diseases.
Li-qin ZHAO ; Jun-hai XIAO ; Wei HUANG ; Song LI
Acta Pharmaceutica Sinica 2002;37(9):743-748
Animals
;
Brain
;
metabolism
;
Humans
;
Nerve Regeneration
;
drug effects
;
Neurodegenerative Diseases
;
metabolism
;
prevention & control
;
Neuroprotective Agents
;
metabolism
;
therapeutic use
;
Tacrolimus Binding Protein 1A
;
metabolism
;
Tacrolimus Binding Proteins
;
metabolism
;
therapeutic use
2.Synergistic activation of p70S6 kinase associated with stem cell factor in MO7e cells.
Younghee LEE ; Hal E BROXMEYER ; Charlie MANTEL ; Hyung Joo KWON ; Jae Wha KIM ; Jin Sook KIM ; Durhan KWON ; In Seong CHOE
Experimental & Molecular Medicine 2003;35(3):222-226
Stem cell factor (SCF) is an early-acting cytokine inducing proliferative synergy with other cytokines in hematopoietic cells. We earlier showed that p21 was synergistically induced in SCF synergy and the p44/42 MAPK pathway was essential for the transcriptional control of p21. SCF synergy accompanies protein synthesis. p70S6K implicated in translational control in many other systems has not been shown in SCF synergy induced system. GM-CSF dependent human cell line MO7e was stimulated with GM-CSF with SCF, and investigated activation of p70S6K by using phospho-specific antibody. A possible contribution of p70S6K to SCF synergy was examined by measuring p21 induction as a model system. p70S6K was slightly activated by GM-CSF alone and markedly activated by SCF alone. Combined stimulation with these two cytokines synergistically activated p70S6K resulting in persistent activation. Addition of the pathway- specific inhibitors for PI3K or FRAP/TOR, two upstream pathways of p70S6K resulted in abolishment of p70S6K phosphorylation and also significant reduction of p21 protein level. These data suggest that synergistically activated p70S6K by GM-CSF plus SCF involves, at least in part, protein translational control including regulation of p21 protein.
1-Phosphatidylinositol 3-Kinase/metabolism
;
Drug Synergism
;
Enzyme Activation
;
Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology
;
Hematopoietic Stem Cells/*enzymology
;
Human
;
Phosphorylation/drug effects
;
Protein-Serine-Threonine Kinases/metabolism
;
Ribosomal Protein S6 Kinases, 70kD/antagonists & inhibitors/*metabolism
;
Stem Cell Factor/*pharmacology
;
Tacrolimus Binding Protein 1A/metabolism
3.FKBP-12 Exhibits an Inhibitory Activity on Calcium Oxalate Crystal Growth in Vitro.
In Sook HAN ; Yasushi NAKAGAWA ; Jong Wook PARK ; Min Ho SUH ; Sung IL SUH ; Song Woo SHIN ; Su Yul AHN ; Byung Kil CHOE
Journal of Korean Medical Science 2002;17(1):41-48
Urolithiasis and calcium oxalate crystal deposition diseases are still significant medical problems. In the course of nephrocalcin cDNA cloning, we have identified FKBP-12 as an inhibitory molecule of calcium oxalate crystal growth. lambdagt 11 cDNA libraries were constructed from renal carcinoma tissues and screened for nephrocalcin cDNA clones using anti-nephrocalcin antibody as a probe. Clones expressing recombinant proteins, which appeared to be antigenically cross-reactive to nephrocalcin, were isolated and their DNA sequences and inhibitory activities on the calcium oxalate crystal growth were determined. One of the clone lambdagt 11 #31-1 had a partial fragment (80 bp) of FKBP-12 cDNA as an insert. Therefore, a full-length FKBP-12 cDNA was PCR-cloned from the lambdagt 11 renal carcinoma cDNA library and was subcloned into an expression vector. The resultant recombinant FKBP-12 exhibited an inhibitory activity on the calcium oxalate crystal growth (Kd=10(-7) M). Physiological effect of the extracellular FKBP-12 was investigated in terms of macrophage activation and proinflammatory cytokine gene induction. Extracellular FKBP-12 failed to activate macrophages even at high concentrations. FKBP-12 seems an anti-stone molecule for the oxalate crystal deposition disease and recurrent stone diseases.
Animals
;
Base Sequence
;
Calcium Oxalate/*antagonists & inhibitors
;
Carcinoma, Renal Cell
;
Crystallization
;
DNA, Complementary
;
Extracellular Space
;
Glycoproteins/genetics
;
Humans
;
Kidney Calculi/*prevention & control
;
Kidney Neoplasms
;
Male
;
Mice
;
Mice, Inbred ICR
;
Molecular Sequence Data
;
Recombinant Fusion Proteins/genetics/metabolism
;
Tacrolimus Binding Protein 1A/genetics/*metabolism